Abstract
Group-level differences in brain macrostructure between individuals at risk for psychosis and healthy controls have been well documented. However, while differences in cortical grey/white matter contrast (GWC), likely reflecting differences in myelin content, have been reported in clinical populations with psychotic disorders, no studies have explored GWC in individuals at elevated risk for psychosis. In this study, we explored whether brain microstructure, as measured with GWC, differs between young adults who endorsed psychotic experiences or genetic high risk for psychosis and healthy controls, and whether individual differences in GWC in at-risk individuals are associated with the number and psychotic experiences. The sample included individuals from two magnetic resonance imaging (MRI) substudies of the Avon Longitudinal Study of Parents and Children (ALSPAC): the psychotic experiences study and the schizophrenia recall-by-genotype study. The final sample included four groups of young adults 19-24 years old: individuals endorsing psychotic experiences (n=119) and health controls (n=117) and individuals with high (n=95) and low genetic risk for psychosis (n=95). Statistical analyses were performed using FSL’s Permutation Analysis of Linear Models (PALM), controlling for age and sex. The results showed no statistically significant differences in GWC between any of the groups and no significant associations between GWC and the number and experiences of psychotic experiences. In conclusion, the results indicate that GWC is not a sensitive neuroimaging marker for psychosis risk in young adults.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this study was provided by Research Council of Norway (RCN, #288083, #323951) and the South-Eastern Norway Regional Health Authority ( #2021070, #2023012, #500189); the RCN and South-Eastern Norway Regional Health Authority had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and Nasimeh Naseri, and Christian K. Tamnes will serve as guarantors for the contents of this paper. Genomicwide genotyping data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. Stan Zammit received funding from MRC (Grant ref: MR/M0067272/1) for the PLIKS interview at age 24.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of ALSPAC Ethics and Law Committee and the Local Research Ethics Committees gave ethical approval for this work. The ethic committee of the Norwegian Regional Committee for Medical and Health Research Ethics gave approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data are available from the Avon longitudinal study of parents and children upon request.
